Loading insider details...
Beta
Latest Form 4 (Sep 9, 2026): Sale of 38,500 TRDA shares, $273.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 38,500 | $273.7K |
| Sep 3, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 29,088 | $205.4K |
| Aug 31, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 38,922 | $280.2K |
| Aug 27, 2026 | Entrada Therapeutics, Inc. (TRDA) | Sale | 21,623 | $158.7K |
| Jan 14, 2026 | Aktis Oncology, Inc. (AKTS) | Conversion | 597,391 | n/a |
| Apr 30, 2025 | Werewolf Therapeutics, Inc. (HOWL) | In-the-Money Exercise | 22,758 | $2.0K |
| Dec 12, 2024 | Entrada Therapeutics, Inc. (TRDA) | Sale | 22,935 | $476.4K |
| Jun 12, 2023 | Repare Therapeutics Inc. (RPTX) | Grant/Award | 27,200 | n/a |
| Jun 6, 2022 | Entrada Therapeutics, Inc. (TRDA) | Grant/Award | 11,918 | n/a |
| May 16, 2022 | Repare Therapeutics Inc. (RPTX) | Grant/Award | 49,000 | n/a |